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Mutations within the central region of prion protein (PrP) have been shown to be associated with severe neurotoxic activity similar to that
observedwith Dpl, a PrP-like protein. To further investigate this neurotoxic effect, we generated lines of transgenic (Tg)mice expressing three
different chimeric PrP-Dpl proteins. Chi1 (amino acids 1–57 of Dpl replaced by amino acids 1–125 of PrP) and Chi2 (amino acids 1–66 of Dpl
replaced by amino acids 1–134 of PrP) abrogated the pathogenicity ofDpl indicating that the presence of aN-terminal domain of PrP (23–134)
reduced the toxicity of Dpl, as reported. However, when the amino acids 1–24 of Dpl were replaced by amino acids 1–124 of PrP, Chi3 Tgmice,
which express the chimeric protein at a very low level, start developing ataxia at the ageof 5–7weeks. This phenotypewasnot counteractedbya
single copyof full-length-PrPc but rather by its overexpression, indicating the strong toxicity of the chimeric proteinChi3. Chi3Tgmice exhibit
severe cerebellar atrophywith a significant loss of granule cells.We concluded that aa25 to aa57 of Dpl, which are not present in Chi1 and Chi2
constructs, confer toxicity to the protein.We tested this possibility byusing the 25–57Dpl peptide in primary culture ofmouse embryo cortical
neurons and found a significant neurotoxic effect. This finding identifies a protein domain that plays a role inmediatingDpl-related toxicity.
Introduction
Prion diseases consist of a group of fatal neurodegenerative dis-
orders characterized by the transition of the cellular prion protein
(PrPc) into an aberrant protein conformer, PrPSc. This form of
PrP is the hallmark of prion infection (Prusiner, 1982). However,
many experiments have shown that PrPSc may not be the proxi-
mate cause of neuronal dysfunction and neurodegeneration (Sol-
omon et al., 2010). Toxicity and infectivity are distinct properties
that do not necessarily coincide (Hill and Collinge, 2003; Mal-
lucci et al., 2003; Solomon et al., 2010; Sandberg et al., 2011).
Several PrPmutants that cause neurodegeneration in the absence
of infectious prion propagation have been studied in transgenic
(Tg) mouse models (Aguzzi et al., 2008). Notably, a category of
mutations within the central region of PrP is found to be associ-
ated with severe neurotoxic activity: mice expressing truncated
PrPc mutants develop specific phenotypes, such as massive de-
generation of cerebellar granule cells (GCs) formutant105–125
(Li et al., 2007) or widespread axomyelinic degeneration for mu-
tant94–134 (Baumann et al., 2007). It has been concluded that
the absence of these segments, called central domains (CDs),
which lie within the highly conserved but unstructured
N-terminal region, is responsible for induced neurodegeneration
characterized by ataxia. This degenerative phenotype is reminis-
cent of the phenotype associated with a PrP-like protein, namely
Doppel (Dpl) (Moore et al., 1999). In PrP-null mice, ectopic
neuronal expression ofDpl leads to ataxia. TheC-terminal region
of Dpl and PrP has a very similar folding pattern with a globular
three-helix region (Mo et al., 2001), therefore Dpl resembles the
neurotoxic PrPmutants cited above, lacking the amino proximal
region.
To understand the dual function of PrP (neurotoxicity vs neu-
roprotection), Baumann et al. (2009) created Tg mice expressing
a fusion protein consisting of the CD of PrP inserted within the
Dpl sequence. These Tg mice failed to develop a Dpl-mediated
typical neurological disorder indicating that the presence of this
N-terminal portion of PrPc reduces the toxicity of Dpl. Here we
report a divergent result. Three Tg lines of mice expressing chi-
meric Dpl-PrP proteins were generated with different localiza-
tions of the PrP-Dpl junction site and length of the Dpl segment.
Two Tg lines, Chi1 and Chi2, did not develop any clinical sign. In
contrast, the third Tg line, Chi3mice, starts developing ataxia at a
very young age. Moreover, in contrast with previously published
Tgmice (Sakaguchi et al., 1996; Shmerling et al., 1998; Rossi et al.,
2001), this phenotype could only be counteracted by PrPc over-
expression, indicating the strong toxicity of the chimeric protein
Chi3. Anatomo-pathological analysis of the cerebellum con-
firmed the phenotype of Chi3 mice. These data led to conclude
that the N-terminal portion of PrP is not sufficient to protect
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from Dpl neurotoxicity. The different phenotypes observed for
Chi1, Chi2, and Chi 3 mice suggested that Dpl neurotoxicity
could be containedwithin aa25 to aa57.We tested this hypothesis
by investigating in vitro the toxicity of this protein segment (pep-
tide D25–57) in mouse embryonic cortical neurons.
Materials andMethods
Animals.Tg andWTmicewere anesthetized (200mg/kg ketamine and 25
mg/kg xylazine, i.p.) and perfused transcardiacally with either 4% para-
formaldehyde in 0.1 M phosphate buffer (PB) or a mixture of 2% para-
formaldehyde and 2% glutaraldehyde in 0.1 M PB. All mice were
maintained under specific pathogen-free conditions. Mice of both sexes
have been used in all experiments.
Ethics statement. All experiments with Tg and non-Tg lines of mice were
conducted according to national and international laws for laboratory ani-
mal welfare and experimentation (EECCouncil Directive 2010/63/EU, Sep-
tember 2010). Experimentswere performedunder the supervisionof J.-Y.C.
(agreement 38 05 17) in the animal care facilities approved by the Direction
des Services Ve´te´rinaires de l’Ise`re (A 38 516 10006).
Construction of the transgenes. The coding region of murine Prnp and
Prnd genes has been cloned previously (Locht et al., 1986; Moore et al.,
1999) and was used as the template to generate the different PrP and Dpl
fragments. The construction of the Chi1 fragment has already been de-
scribed (Erlich et al., 2008). To create the Chi2 fragment, murine Prnp
and Prnd ORFs were used as the template to obtain two PCR fragments
(PrP2 andDpl2) with primer set P1 (5-CGATGTCCAGCTTCCTGCTC
ATGGCGCTCC-3) and P2 (5-ACGCGTGCAGATCAGTCATCATGG
CGAACCTTGGCTACTGG-3) and primer set P3 (5-GGAGCGCCAT
GAGCAGGAAGCTGGACATCG-3) and P4 (5-ACGCGTCCCTTACT
TCACAATGAACCAAACGAAACCCAGC-3), respectively. To create
the Chi3 fragment, we used primer set P5 (5-TATGCCCCTTGCTTTA
AGGCCCCCCACTAC-3) and P2 and primer set P6 (5-GTAGTGGG
GGGCCTTAAAGCAAGGGGCATA-3) and P4 to amplify, respectively,
the PrP and Dpl fragments (PrP3 and Dpl3). To generate the chimeric
fragments Chi2 and Chi3, the two initial PCR products (PrP2 and Dpl2
forChi2 andPrP3 andDpl3 forChi3)were then fused in a third PCRwith
the flanking primers P2 andP4. These products were then cloned into the
pCR2.1-Topo vector (Invitrogen). The 3F4 epitope (L109M/V112M)
was introduced by using the QuikChange site-directed mutagenesis kit
(Stratagene, Agilent Technologies) according to the manufacturer’s in-
structions. All mutations were verified by sequencing. A 692 bp fragment
was then amplified using the primers P7 (5-GGAGGGTGGAACACCG
GTGGAAGCCGGTAT-3) and P8 (5-GGAAGGCCTCC CTCACTTC
ACAATGAACCA-3). The 5 primer is homologous to the region from
positions 184 to 213 of the murine Prnp cDNA (GenBank accession
numberM13685) and possessed an Age1 restriction site. The 3 primer is
complementary to the 3 end of the murine ORF [starting at nucleotide
876 and includes 15 nt complementary to the murine Dpl sequence
(nucleotides 36749 to 36763; GenBank accession number U29187). An-
other PCRwas performed using P9 (5-TGGTTCATTGTGAAGTGAGG
GAGGCCTTCC-3) and P10 (5-GGCTGTTTTCCAGGGCGCCATCC
CC-3) as the 5 and 3 primers and half-genomic vector (pHGPrP)
(Fischer et al., 1996) containing a single Nar1 restriction site (pHGPrP-
mutNarI) (Erlich et al., 2008) as the template, to amplify part of the 3
murinePrnp untranslated region (UTR). For each construct (Chi1, Chi2,
and Chi3), both amplified fragments (Chi1 ORF, Chi2 ORF, Chi3 ORF,
and the murine 3 UTR) were fused in a third PCR with the flanking
primers P7 and P10. These products were digested with Age1/Nar1 and
ligated into the Age1/Nar1 site of pHGPrPmutNarI. The presence of the
new inserts was confirmed by sequencing of the ORF.
Generation, identification, and maintenance of Tg mice. The transgene
fragments containing chimera coding sequenceswere cut out frompHG-
PrP vector with NotI and SalI. Pronuclear injection was performed into
oocytes of hybrid C57BL6/SJL mice. Tg mice were generated by micro-
injecting the purified transgene fragments into the pronucleus of
Prnp/ single-cell embryos (C56BL/6  DBA/2 F1 hybrids) and im-
planted into pseudo-pregnant female mice. Founder mice were identi-
fied by genomic PCRwith transgene-specific primers (P11, 5-GCGGCG
CCATCCCCAAACAGTGGCTTC-3;P12,5-CCTAGGAGCCTTCATC
AAGCAAGGCCGG-3), producing an 770 bp fragment for the Chi1
and Chi3 transgenes. Chi2 mice were identified with a second set of
primers (P13, 5-AACTATTGGCAGTTCCCTGATGGG-3; P14, 5-CT
CTGGGTACAAGTCAGGGGATACACC-3). Founder mice were bred
with C57BL/6Jmice to produce F1 hemizygousmice for expression anal-
ysis. In general, Tgmiceweremaintained as hemizygotes by backcrossing
to the C57BL/6J strain for five to six generations. Tg founders were then
serially crossed with C57BL/6J ZrchI Prnp 0/0 mice. All Tg lines were
maintained in the Prnp/ or Prnp 0/0 allelotype. Chi3 mice were also
maintained in the Prnp/0 allelotype. To test for the presence of Prnp
alleles, additional PCR was performed using primers P15 (5-TCATGC
CCATTTCCAAATTCCACTACA-3), P16 (5-GGGTAGCGGTACAT
GTTTTCACGGTAG-3), and P17 (5-ACGCGTCACCTTAATATGCG
AAGTGGA-3). A fragment of 566 bp indicates the presence of the
Prnp 0/0 allele, whereas a product of 779 bp is detected for the Prnp/
allele. Heterozygous mice display both amplicons. Chi3Prnp/ mice
were crossedwith tga20micewith a pure C57Bl6J background andmain-
tained on tga20/Prnp/. The presence of tga20 allelewas detected by
PCR using primers P16 and P18 (5-ACTCTTCATTTTAGGCCCCACG
TATCA-3), producing an 1066 bp fragment. The transgene copy
number was calculated by dot blot assay on genomic DNA.
Anti-PrP and anti-Dpl antibodies. Anti-PrP monoclonal antibodies
(mAbs) were gifts from Jacques Grassi (CEA, Gif sur Yvette, France).
SAF32 recognizes amino acids 59–89 in the N-terminal domain of mu-
rine PrP and thus can also detect the chimeric protein (dilution, 1:5000).
MousemAb3F4 (Kascsak et al., 1987) raised against humanPrP 109–112
was diluted 1:5000 forWestern blot. Rabbit polyclonal anti-Dpl antibody
was obtained by immunizing rabbits with recombinant full-length Dpl
[expression and purification of Dpl has been described in previous work
(Erlich et al., 2008)]. Sera were tested by Western blotting using total
protein extracts from mouse testis for their ability to detect cellular Dpl
(dilution, 1:7500).
Western blot. Brain homogenates (10% w/v) were prepared in a lysis
buffer containing 150 mM NaCl, 0.5% Triton X-100, 0.5% sodium de-
oxycholate, 50 mM Tris-HCl, pH 7.5, 2 mM EDTA, and 1M of proteases
inhibitors pepstatin and leupeptin (both from Roche Diagnostics). After
10 min of centrifugation at 3000 g, the supernatant was collected, and
its total protein concentration was determined by the bicinchoninic pro-
tein assay (Uptima; Interchim). For PrPc and chimera detection, the
equivalent of 30 g of total protein was mixed with reducing Laemmli
buffer, boiled at 100°C for 5 min, and subjected to 12% SDS-PAGE. The
proteins were transferred (400 mA for 60 min) onto a nitrocellulose
membrane (Trans-Blot Transfer Medium, 0.2m; Bio-Rad). The mem-
brane was then rinsed in PBS for 5 min and blocked with 3% BSA in
PBS–0.1% Tween 20. The next day, the membrane was rinsed two times
for 10 min in PBS–0.1% Tween 20 and incubated 1 h at room tempera-
ture with the appropriate primary antibody diluted in PBS–0.1% Tween
20. After washing, the membrane was incubated with the secondary an-
tibody [goat anti-mouse HRP conjugate or goat anti-rabbit HRP conju-
gate (both 1:10,000; Jackson ImmunoResearch Laboratories)] for 60
min. Blots were developed by enhanced chemiluminescence (ECL; GE
Healthcare) and exposed on X-ray film (Hyperfilm ECL; GEHealthcare)
or analyzed with the ChemiDoc XRS system (Bio-Rad). Commercially
available monoclonal anti-actin (1:10,000; Sigma-Aldrich) antibody was
used for controls. For deglycosylation, 50 g of denatured total protein
from brain lysates was incubated at 37°C for 4 h with 500 U of PNGase F
(New England Biolabs), according to the manufacturer’s instructions, in
the presence of protease inhibitors leupeptin and pepstatin (10 g/ml).
Reaction was stopped by adding reducing Laemmli buffer, and samples
were analyzed byWestern blotting as described above. Quantification of
Western blots was performed using ImageJ densitometry software.
Flotation assays. Appropriate brain homogenates were extracted for
2 h on ice in cold lysis buffer (150 mM NaCl, 25 mM Tris–HCl, pH 7.4, 5
mM EDTA, 1% Triton X-100; total protein, 1 mg in 1 ml). Extracts were
mixedwith 2 vol (2ml) of 60%Optiprep (Sigma-Aldrich) to reach a final
concentration of 40%. All lysates were loaded at the bottom of ultracen-
trifuge tubes (Sorvall). An Optiprep step gradient in a buffer containing
150 mM NaCl, 25 mM Tris–HCl, pH 7.4, and 5 mM EDTA was then
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overlaid onto the lysate (6 ml of 30% Optiprep and 2.5 ml of 5% Op-
tiprep). Tubes were centrifuged for 24 h at 4°C in a T-641 rotor (Sorvall)
at 100,000 g. Fractions (1 ml) were collected from the top of the tube.
The equivalent of 300 l of each fraction was treated with 3 vol of meth-
anol (900 l), 1 vol of chloroform (300 l), and 3 vol of H20 and centri-
fuged for 5 min at 4°C at 10,000  g. Aqueous upper phase was
eliminated, and proteins were precipitated with 3 vol of methanol and
centrifuged as above. The pellet was dried, resuspended in reducing
Laemmli buffer, and processed for immunoblotting and visualization
with anti-PrP SAF32 and 3F4 antibodies.
Behavioral assessment.Allmice were examined twice weekly for behav-
ioral abnormalities, such as trembling gait, disorientation, kyphosis,
rough hair coat, and paresis that could rapidly progress to severe ataxia.
The onset of ataxia is defined by the clear appearance of trembling. For
ethical reasons, the mice were killed when the following neurological
symptoms were observed: feet clasping when lifted, paresis of the hind
legs, and prostration. Motor performance was evaluated with a rotating
rod apparatus (Accelerating Model; Ugo Basile Biological Research Ap-
paratus). Mice were placed on a rotating rod with a speed slowly accel-
erating from 4 to 40 rpm. Maximum speed was reached after 240 s. We
recorded the latencies at which the animal fell off the rod. The median
latency to fall was tested three times in a row with an interval of 30–60
min between trials. Mice were tested from 12 to 25 weeks of age on a
weekly or biweekly basis.
Histology and immunohistochemistry. Sagittal paraffin sections were
cut from paraformaldehyde-fixed cerebellum of mice. Sections were se-
lected at 10 equidistant levels along the transverse dimension of the cer-
ebellum, mounted on slides, and submitted to Mason’s trichrome
staining (Kascsak et al., 1987) and to a classical immunoperoxidase stain-
ing protocol for detection of calcium binding protein (CaBP) in Purkinje
cells (PCs), glial fibrillary acidic protein (GFAP) in astrocytes, andNeuN
in granule cells. Briefly, the deparaffinized sections were incubated over-
night at 4°C in the primary antibody (anti-CaBP, 1:300, Sigma-Aldrich;
anti-NeuN, 1:1000, Millipore; anti-GFAP, 1:300, Sigma-Aldrich) solu-
tion of 0.1 M PBS containing 0.3% Triton X-100 after rinsing for 45 min
in 3% normal horse serum (NHS) in PBS containing 0.5% Triton. The
sectionswere then rinsed in PBS before incubation in secondary antibod-
ies (biotinylated horse anti-mouse 1/200 (CaBP, GFAP) and 1/400
(NeuN) diluted in PBS containing 0.3% NHS. After rinsing in PBS, the
secondary antibodies were revealed for 1 h with streptavidin–horserad-
ish peroxidase complexes (Vector Laboratories) and subsequent reaction
in diaminobenzidine (2 min). The sections were dehydrated in ethanol
and mounted in Eukitt.
Morphometry in Mason’s trichrome-stained and immunostained sec-
tions.The length of the Purkinje cell layer (PCL) wasmeasured in each of
the 10 Mason’s trichrome-stained cerebellar sections from each mouse
using ImageJ software. Statistical comparison between the mean lengths
measured in each animal was achieved using a Student’s t test (p 0.01,
p 0.05). The number of CaBP-positive PCs per millimeter of PCL was
counted in each of the 10 CaBP immunostained sections from each
mouse using ImageJ. Statistical comparison between the mean PC num-
ber/millimeter of PCL ratiosmeasured in each animalwas achieved using
a Student’s t test (p  0.01). The surface of the internal granular layer
(IGL) and of NeuN immunoperoxidase-stained area, which mostly con-
cerned granule cell nuclei in the IGL, were measured using ImageJ to
estimate the density of granule cells by the ratio between the NeuN im-
munostained IGL area and the IGL area in each of the 10 NeuN immu-
nostained sections from each mouse. Both mean IGL surfaces and mean
granule cell densities were statistically compared between the different
mice using a Student’s t test (p 0.05).
Morphometry in Toluidine blue-stained semithin sections. Sagittal vi-
bratome sections were cut in the glutaraldehyde/paraformaldehyde-
fixed cerebellum and postfixed in osmium tetroxide before classical
processing for flat embedding in Araldite. Four sagittal semithin sections
were cut from the whole cerebellum of each mouse in the right and left
hemispheres (n  1 section/hemisphere) and in the vermis (n  2 sec-
tions). These sections were stained with Toluidin blue, and the length of
the PCL was measured using ImageJ. A mean PC number per millimeter
of PCL was estimated in the hemispheres and vermis of each mouse by
counting the total number of PCs in each section. In addition, the perim-
eter and surface of each vermal section weremeasured using ImageJ. The
mean values of PC number per millimeter (p  0.01) and of cerebellar
vermis perimeter and surface (p  0.01–0.05) were compared between
each mouse using a Student’s t test.
Transmission electronmicroscopy. Four blocks were randomly sampled
in the cortex and deep nuclei in each of the four Araldite-embedded
vibratome sections of cerebellar hemispheres and vermis of mice. Ultra-
thin sections were cut from each bloc and examined with a transmission
electron microscope (Hitachi 7500). In each mouse, 23–38.104 m2
were observed throughout the cerebellar cortex (14–20.104 m2) and
deep nuclei (8–22.104m2), and the ultrastructural content of 120–230
PC somata was examined.
Primary neuron culture and toxicity assay. Cortices from C57Bl6 
129/Pas E17.5 mice embryos were isolated and chemically and mechan-
ically dissociated as described previously (Dotti et al., 1988). Two hemi-
spheres produced a cell suspension plated on poly-L-lysine-coated P96
wells (BD Biosciences) in DMEM plus 10% FBS, replaced with Neuro-
basal medium supplemented with B-27 (Invitrogen) about 90 min later.
After 3 d in vitro (DIV), 3 M cytosine -D-arabinofuranoside (Sigma-
Aldrich) was added in fresh medium to prevent proliferation of non-
neuronal cells. At 8 DIV, the indicated concentrations of peptide in H2O
were added in fresh medium. After an additional 3 DIV, survival of
cortical neurons was tested by adding 10 l of the cell proliferation
reagent CCK-8 to eachwell, according to themanufacturer’s recommen-
dations (Dojindo Molecular Technologies). The optical density at 450
nm (reference, 650 nm) was measured 0.5, 1, 2, and 4 h later, using a
microplate reader (PHERAstar; BMG Labtech). Background-subtracted
results were plotted in Prism5 (GraphPad Software) and analyzed using a
two-way ANOVA test followed by Bonferroni’s post hoc tests.
Peptide. The murine sequence of the Dpl protein fragment D25–57,
KARGIKHRFKWNRKVLPSSGGQITEARVAENRPG, and its control
scrambled peptide, VGPKAWKTSLGKFRQVGRPESRNHIKAARIEN
RG, were purchased from Genosphere Biotechnologies. These peptides
were dissolved in water at a concentration of 10 mM, distributed in 20 l
aliquots, and stored at20°C until used.
Statistics. Statistical analysis was performed using Prism 4 (GraphPad
Software). Results are shown as the means 	 SEM. Nonparametric
Mann–Whitney tests were used to compare statistical differences between any
two groups. Formore than two groups, a one-wayANOVAwas used, followed
byBonferroni’s post hoc comparisons orTukey’s post hoc comparisons.
Results
Characterization of Tg mice expressing chimeric
PrP-Dpl proteins
To study the effect of PrP on Dpl toxicity in the brain, we created
three chimeric PrP-Dpl constructs. The first two, Chi1 and Chi2,
consisted in the N terminus of PrP comprising, respectively,
codons 1–125 and 1–135 fused to the C terminus of Dpl compris-
ing, respectively, codons 58–179 and 66–179. These particular
junctions were chosen because secondary structure comparisons
and hydrophobic predictions suggested that the resulting chime-
ric proteins would resemble wild-type PrPc, Chi1 having its first
 strand from Dpl and Chi2 from PrP (Fig. 1). In contrast, we
designed a third construct (Chi3) to have the full-length Dpl
(25–179) fused to the same N terminus of PrP as Chi1 (Fig. 1).
To overcome the simultaneous detection of the chimeric and
endogenous PrP proteins in mice expressing endogenous Prnp,
we inserted two amino acid substitutions from human PrP,
L109MandV112M,which are included in the epitope recognized
by 3F4 anti-PrPmAb (Kascsak et al., 1987). Four Chi1, one Chi2,
and one Chi3 founder mice were found to carry the transgenes.
The Chi1, Chi2, and Chi3 Tg lines selected for additional studies
harbored, respectively, 15, 10, and 15 copies per haploid genome.
Tg mice were maintained as hemizygotes by serial backcrossing
to the C57BL/6J strain and were then successively intercrossed
with nonataxic PrPc-deficient Zu¨rich-I mice [Prnp0/0 (Bu¨eler et
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al., 1992)] previously bred on the C57BL6/J background (Loeuil-
let et al., 2010). In this way, offsprings carrying a single allele of
the Chi transgene associated or not with the endogenous Prnp
gene (Chi/ and Prnp/, Chi/ and Prnp/0, Chi/and
Prnp0/0) were obtained. Because we have only used heterozygous
Chi Tg mice, Chi/ Tg mice will be referred as Chi mice for
convenience.
Expression of the chimeric proteins was analyzed by Western
blotting. ThemAb 3F4 (Kascsak et al., 1987) allowed detection of
protein bands between 30 and 43 kDa in the brain tissue homog-
enates from Chi1, Chi2, and Chi3 mice (Fig. 2A). The analysis
indicates significant expression of Chi1, 10–15 times higher than
Chi2 and 20–25 times higher than Chi3. Chi3 showed a lower
electrophoretic mobility than Chi1 and Chi2, as a result of the
additional 33 aa present in the Dpl portion of Chi3. The expres-
sion of each chimeric protein was similar, whatever the Prnp/
or Prnp0/0 background, suggesting that removal of the WT Prnp
alleles did not downregulate or upregulate the expression of the
Chi proteins in the brain of Chi Tgmice (Fig. 2A). To quantify the
expression of the chimeric proteins against the WT and tga20
mice, a mouse line overexpressing PrPc at about 6–10 times the
WT level (Fischer et al., 1996), we performedWestern blots using
the SAF32 mAb (Kascsak et al., 1987). This mAb is directed
against amino acids 79–92 of the N-terminal portion of mouse
PrPc. As shown in Figure 2B, the expression of Chi1 was much
higher than that of PrPc in WT mice, almost at the same level as
PrPc in tga20mice, whereas Chi2 andChi3 expression levels were
5- to 10-fold lower than that of PrPc inWTmice. As Chi proteins
are detected as several bands, we also investigated the chimeric
proteins after PNGase-F treatment. As shown in Figure 2C, the
Chi proteins detected with the 3F4 mAb was reduced to a single
band of lower molecular weight, indicating that these proteins
were N-glycosylated. Both Dpl and PrPc have been found to as-
sociate with membrane microdomains enriched in cholesterol
and sphingolipids known as detergent-resistant membrane or
lipid rafts (Shyng et al., 1995; Taylor andHooper, 2006; Caputo et
al., 2010). To investigate the localization of the chimeric proteins,
we performed flotation assays on OptiPrep gradients using cold
Triton X-100-treated brain extracts from Tg mice. As shown in
Figure 2D, chimeric proteins were detected in low-density
fractions and displayed buoyancy similar to that of PrP c,
whose cellular localization in raft is well established (Sunyach
et al., 2003; Chen et al., 2009). The molecular weight and the
migration profile of Chi1, Chi2, and Chi3 protein in the raft
are similar to what is observed in whole-brain extract (Fig.
2A,B). Together, these data indicated that the chimeric pro-
teins are properly expressed, correctly processed to the cell
surface, and localized in lipid rafts.
Figure 1. Schematic representation of WT PrP, Dpl, and chimeric PrP/Dpl mutants (Chi1,
Chi2, and Chi3). Sequences are hatched for PrP and white for Dpl. SP, Secretory signal peptide,
cleaved during synthesis; OR, octarepeats, five repeats of eight amino acids; 1–3 and1–3,
-helices 1, 2, and 3 of the globular C-terminal domain of PrP and Dpl, respectively;1–2 and
1–2, sheets 1 and2of PrP andDpl, respectively; GPI, sequence cleavedafter attachment of
the glycosylphosphatidyl inositol anchor; 3F4, epitopes recognized by the mAb 3F4 (white
arrowhead). For chimeric constructs, the junctions betweenPrP andDpl are indicated by a black
arrowhead.
Figure 2. Expression of Tg proteins. A, The expression levels of each chimeric protein are
independent of the Prnp status (Prnp/ or Prnp 0/0). Thirtymicrograms of protein from crude
brains homogenatewere loaded.B, Expression of chimeric protein in brain comparedwith that
of PrP in WT and tga20mice. Chi3 expression is lower than that of WT PrP. Amounts of protein
(in micrograms) loaded for each line are indicated on the top of the gel. C, The glycosylation
pattern of full-length Chi proteins is similar in Chi Tg mice expressed on mouse Prnp/and
Prnp 0/0 background. Thirtymicrograms of protein from total brain homogenates are subjected
() or not () to PNGase F treatment. D, Analyses of density gradient of detergent-resistant
membranes from brains of WT, Chi1, Chi2, and Chi3 mice (on Prnp/ and Prnp 0/0 back-
ground).Western blotswere performedwithmAbSAF32 (B,D; ChiPrnp 0/0 Tgmice) ormAb3F4
(A, C,D; ChiPrnp/ Tgmice).Molecular sizemarkers (in kilodaltons) are indicated on the left.
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Ataxia in Chi3 mice
The three Chi lines were maintained on the Prnp/, Prnp/0,
and Prnp0/0 allelotype and monitored for abnormal behavior.
The hemizygous Chi1 and Chi2 mice did not elicit any clinical
syndrome on the Prnp/ or Prnp0/0 background, up to 2 years.
These results confirmed the previous data obtained (Yoshikawa
et al., 2008; Baumann et al., 2009) indicating that the presence of
N-terminal portions ([1–125] for Chi1 and [1–135] for Chi2) of
PrP suppress the toxicity of Dpl (Aguzzi et al., 2008). However,
although the Chi3 protein was expressed at a very low level in the
heterozygous Tg mice on the Prnp/ background, these mice
developed early motor deficits (47 	 11 d) that progressed with
age. The earliest symptoms were coarse tremor followed by a
progressive inability to stride on cage grids. The mice then devel-
oped paresis of the hind legs, which progressed to full paraplegia
(Fig. 3A). Ultimately (324 	 99 d), they were severely handi-
capped in their movements and were killed. These data indicated
that, contrary to Chi1 and Chi2, Chi3 protein retained the neu-
rotoxic property of Dpl.
Impact of PrP expression on ataxia in Chi3 mice
The PrP knock-outmice with ectopic neuronal expression of Dpl
exhibit spontaneous ataxia that can be rescued by introduction of
aWT Prnp allele (Nishida et al., 1999; Moore et al., 2001; Rossi et
al., 2001). Therefore, we developed mice on the following geno-
types: (1) Chi3Prnp/, (2) Chi3Prnp/0, (3) Chi3Prnp0/0, (4)
Chi3tga20/Prnp/0, and (5) tga20/Prnp/0. The age of on-
set of ataxia was compared between the various Prnp background
Tgmice (Fig. 3B). Trembling gait appeared at 35 d inChi3Prnp0/0
mice (n  12) and at 38 and 47 d, respectively, in Chi3Prnp/0
(n 37) andChi3Prnp/ (n 38)mice. The onset of ataxiawas
observed in all thesemice within 65 d. In contrast,40% ofmice
bred on tga20 background (n 8) started to show slight clinical
signs at 80 d (Fig. 3B). These data showed that the suppression of
two alleles of Prnp shortened significantly the onset of ataxia
phenotype, whereas it appeared to be partially rescuedwhen PrPc
is overexpressed on tga20 background (p 0.001 for each com-
parison,Mann–Whitney test). Furthermore,mice showed signif-
icantly faster progressive symptoms of ataxia, i.e., 91 d for
Chi3Prnp0/0 mice compared with 122 d for Chi3Prnp/0 and
182 d for Chi3 Prnp/. Survival was significantly shorter than
for Chi3Prnp/mice (p 0.001; Fig. 3C), whereas none of the
Chi3 tga20/Prnp/0 mice progressed to a severe ataxia (up to
386 d).
To further investigate the ataxia in Chi3 mice linked to differ-
ent Prnp backgrounds, we studied the locomotor function, by
measuring the latency to fall from an accelerating Rotarod device
(Fig. 3D). Themice testedwere between 12 and 28weeks old. The
12-week-old Chi3Prnp/0 mice, which presented clinical signs,
could not stay on the rod for longer than 13 s (n  5), whereas
Chi3 mice overexpressing PrP (Chi3tga20/Prnp/0) fell after
104 s (n 5). The control mice (tga20/Prnp/0) that did not
express Chi3 performed better with an average time of 157 s (n
5). These data showed that Chi3tga20/Prnp/0 performed
better than Chi3Prnp/0 (p  0.0001, ANOVA followed byFigure 3. Phenotypic analysis of Chi3 mice. A, Typical clinical phenotypes at the terminal
stage: ataxia (left), kyphosis (middle), and claspingwhen held head down by the tail (right).B,
Chi3 mice were maintained on the Prnp/ (n 38), Prnp/0 (n 37), Prnp 0/0 (n 12),
and Prnp/0tga20/ (n  8) allelotypes and monitored for the onset of the ataxia.
Chi3Prnp/0 and Chi3Prnp 0/0 mice start showing coarse tremor slightly more rapidly than
Chi3Prnp/ ( p 0.001, Mann–Whitney test), whereas most Chi3tga20/Prnp/0 re-
main asymptomatic. C, The mice were killed when the following neurological symptoms were
observed: feet clasping when lifted, paresis of the hind legs, and prostration. The survival of
mice is dependent of Prnp status, with Chi3Prnp/0 and Chi3Prnp/mice surviving longer
than Chi3Prnp 0/0 ( p0.001,Mann–Whitney test), whereas Chi3tga20/Prnp/0mice
4
havea longer life expectancy (400d).D, Rotarod testing inaccelerationmodeof Chi3Prnp/0
(n 5), Chi3tga20/Prnp/0 (n 5) and tga20/Prnp/0 (n 5) mice. Overexpres-
sion of WT PrP c improves rotarod performance in Chi3 mice (Chi3tga20/Prnp/0, p
0.0001). This improvement still differs from tga20/Prnp/0 control mice. Chi3Prnp/0
mice continue to deteriorate, not being able to stay on the rod from19weeks of age. Significant
differences were tested using one-way ANOVA with Tukey’s post hoc comparison.
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Tukey post hoc tests), but not as well as control mice (tga20/
Prnp/0, p 0.0001). The performances of Chi3Prnp/0 dimin-
ished rapidly over time since they could not stay on the rod when
older than 19 weeks. In contrast, the Chi3tga20/Prnp/0 mice
fell with a constant latency up to 26 weeks of age. These results
suggested that the severity of the ataxic phenotype displayed by
Chi3Prnp/0 mice was partially reversed by overexpression of
WT PrPc.
Neuropathological changes
Histological examination of either Mason’s trichrome- or Toluidin
blue-stained sections of Chi3 cerebellar tissue did not disclose evi-
dent structural abnormalities. Nevertheless, the size of the cerebel-
lumof the3-month-old ataxicChi3Prnp/ (Fig. 4B)wasobviously
reducedcomparedwith thatof thenon-Tg littermateof the sameage
(Fig. 4A).This reductionwas alsoobserved inChi3Prnp/0 (Fig. 4C)
and Chi3Prnp0/0 (Fig. 4D)mice from 3 to 13.5 months of age. This
phenotypewas not observed inChi1mice,which are not ataxic (Fig.
4H,G). On tga20/ background, the Chi3 cerebellum (Fig. 4F)
was not reduced compared with the control tga20/ mice (Fig.
4E). This observation was confirmed by morphometrical analyses
that revealed a significant reduction (60%)of the area of the cerebel-
lumof these Chi3Prnp/mice (p 0.01, Student’s t test), whereas
no difference was observed between Chi3tga20/ and tga20/
mice (Fig. 5A).
The impact of the expression of PrP-Dpl chimeras on the PC
population was investigated by specific CaBP immunohistochemi-
cal staining of these neurons in the cerebellar cortex of the Tgmice.
In the vermis of the cerebellum, CaBP-positive PCs did not exhibit
any obvious alteration of their somato-dendriticmorphology in the
cerebellar molecular layer of Chi3Prnp/, Chi1Prnp/, andWT
mice (Fig. 6A–C). Nevertheless, in the Chi3 mice (Fig. 6B), the PCs
appeared to be kept closer together in the PCL than in theWT (Fig.
6A) and in the Chi1Prnp/ (Fig. 6C) mice. Quantifying the num-
ber of PCs per millimeter of PCL length in Toluidin blue-stained
semithin sections showed that the linear density of PCs was sig-
nificantly greater in Chi3 mice than in WT mice (Fig. 5B) (p 
0.01, Student’s t test). This was observed at all ages of Chi3 mice,
whatever their Prnp genetic background.
However, in Chi3 mice overexpressing
Prnp (Chi3tga20/Prnp/0), such an
increase of PC density was not observed,
compared with the nonchimeric tga20/
(tga20/Prnp/0) mice as shown in
Figure 5B.
The granule cell population was ana-
lyzed using NeuN immunohistochemical
staining in the cerebellar cortex of all Tg
mice. As opposed to the Purkinje cells, the
granule cell density was lower in the IGL
of the Chi3 mice than in the IGL of the
WT and Chi1Prnp/ mice (Fig. 6D—
F). Indeed, cell quantification showed
that the mean density of the NeuN-
stained GC was significantly reduced in
the Chi3 mice compared with WT mice (Fig. 5C) (p  0.05,
Student’s t test). This was observed throughout the cerebellum as
early as 3 months up to 13.5 months of age, whatever the Prnp
background of the mice. The reaction of astrocytic glia to PrP-Dpl
expression was analyzed using GFAP immunohistochemistry in the
cerebellum of all Tg mice. In the cerebellar cortex of the WT (Fig.
7A,D) and Chi1 (Fig. 7C,F) mice, GFAP-positive astrocytes were
stained throughout the PCL and IGL whereas parallel processes of
Bergman glia were faintly stained in the molecular layer (ML). In
contrast, in the cerebellumof theChi3mice, an important astrocytic
gliosis was observed, particularly prominent in the PCL and IGL as
well as in Bergman glia in theML (Fig. 7B,E).
The ultrastructure of the cerebellar cortex was then investi-
gated by transmission electron microscopy in the Chi3 mice. In
the IGL of these mice, abnormal wrapping of glial profiles was
frequent (Fig. 8A), confirming the astrocytic reaction evidenced
Figure 4. Histological studies. Toluidine blue (A–F) and Mason’s trichrome (G, H)
histological staining of sagittal sections in the cerebellum of 3-month-old WT mice (A),
Chi3Prnp/ mice (B), 2-month-old Chi3Prnp/0 mice (C), 3-month-old Chi3Prnp 0/0
mice (D), tga20/ mice (E), Chi3tga20/ mice (F), 8-month-old WT mice (G), and
11-month-old Chi1Prnp/ mice (H). Scale bar, 500m.
Figure 5. A, Mean area of the median cerebellar vermis in 3- to 8-month-old WT mice (n  2), 3- to 13.5-month-old
Chi3Prnp/ mice (n 4), 3-month-old tga20/ mice (n 2), and Chi3tga20/ mice (n 2) (*p 0.01). B, Mean
number of PCs permillimeter of PCL in Toluidin blue-stained semithin sections of themedian cerebellar vermis of 3- to 8month-old
WT mice (n 2), 3- to 13.5-month-old Chi3Prnp/mice (n 4), 3-month-old tga20/mice (n 2), and 3-month-old
Chi3tga20/mice (n 2) (*p 0.01). C, Mean density of NeuN immunolabeled GCs in the IGL in sagittal paraffin sections of
themedian cerebellar vermis of 3- to 8-month-oldWT (n 2) and 3- to 13.5-month-old Chi3Prnp/ (n 4)mice (*p 0.05).
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by GFAP immunohistochemistry. However, the mossy fiber–
granule cell glomerules displayed a normal aspect and composi-
tion (Fig. 8A). More spectacular abnormalities were observed
within themyelinated PC axons, which contained piles of tubules
(Fig. 8A) or autolysosomal profiles. In some cases, groups of
degenerated GCs displayed electron-opaque content of various
sizes (Fig. 8B). The PCs of the Chi3 mice presented several so-
matic as well as dendritic abnormalities. Autophagic-like phago-
phores born from trans saccules of Golgi dictyosomes were
frequently found in the PC soma and main dendrites, which also
contained stacked endoplasmic reticulum profiles (Fig. 8C) and
numerous dense bodies distinct from the classical lipofuchsin
bodies. Stackedmembranes (Fig. 8D) and phagophores as well as
putative autolysosomes were also found in large and tertiary PC
dendrites. Although we did not quantify PC spines and their
presynaptic partners, we observed PC spines embedded in the
surrounding glia, free of any presynaptic innervation (Fig. 8E). In
the deep cerebellar nuclei, myelinated axons displayed similar
abnormal structures such as stacked tubules and autophagolyso-
somes as observed in the IGL. However, we did not find any
alterations of the PC terminals synapsing symmetrically on the
dendrites of the deep cerebellar neurons (Fig. 8F). As we did not
observe any loss of PCs in the cerebellar cortex of the Chi3 mice
compared with the WT mice, the ultrastructural abnormalities
observed in these cells result from the loss of GCs, amain afferent
input of the cerebellar cortex, which likely underlies the ataxic
phenotype of the Chi3 mice.
D25–57 peptide toxicity
It has been described that PrPc can suffer a proteolytic cleavage at
amino acids 110/111 or 111/112, leading to the production of the
C-terminal fragmentC1 (Mange´ et al., 2004). The ectopic expres-
sion of Dpl in brain neurons is known to be the primary cause of
ataxia (Moore et al., 2001; Rossi et al., 2001). Since the C1 cleav-
age site is present in Chi3 construct, we tested for the release of a
C1 equivalent Dpl fragment from Chi3 protein, which could re-
sult in neurotoxicity. Because the cleavage would occur within
the linear 3F4 epitope, the putative Dpl fragment can only be
recognized by an anti-Dpl antibody. Thus, Western blot analysis
of PNGase-F-treated samples was performed using a rabbit poly-
clonal antibody directed against the full-length Dpl protein (Fig.
9). Brain homogenate from Dpl-overexpressing Prnpngsk/ngsk
mice and from WT mice as well as WT testis homogenate were
added as controls. As expected, a Dpl-specific signal could not be
observed in the brain sample of WT mice (Fig. 9). Testis control
showed a heterodisperse signal between 29 and 37 kDa. Subse-
Figure 6. Calcium-binding protein immunoperoxidase staining of the Purkinje cells in the
cerebellum of 8-month-old WT (A) and Chi3Prnp/ (B) mice and 11-month-old
Chi1Prnp/mice (C). NeuN immunohistochemical staining of the GCs in themedian cerebel-
lar vermis of 8-month-oldWT (D) and Chi3Prnp/ (E)mice and 11-month-old Chi1Prnp/
mice (F). Scale bars, 50m.
Figure 7. Immunohistochemical staining of GFAP in the cerebellum of WT, Chi3, and Chi1
mice.A,B,D, E, Vermal sections and cortex of the dorsal side of the lobule IXa of the cerebellum
of 8-month-old WT (A, D), 8.5-month-old Chi3Prnp/ (B, E), and 11-month-old
Chi1Prnp/ (C, F) mice. GFAP overexpression signals reactive astrogliosis in Chi3 mice com-
pared with WT and Chi1Prnp/. Scale bars: A–C, 50m; D–F, 200m.
Figure 8. Ultrastructure analysis. A, B, Ultrastructure of the internal granular layer of Chi3
mice. A, A mossy fiber terminal (mf) makes asymmetric synapses (arrowheads) with GC den-
drites (GD) and is surrounded by abnormalwraps of glial profiles (g). Amyelinated PC-like axon
contains an abnormal crystalloid stacking of tubular profiles (*). B, Steps of GC degeneration
fromshrunken cell bodywith cytoplasmic electron-opaqueprofiles (arrows) to overall electron-
opacity of the neurons (*). See the normal-like GC on the right side. C–F, Ultrastructure of
abnormal profiles in PC somata and dendrites of Chi3 mice. C, Autophagic-like phagophore (*)
forming from the trans saccules of a Golgi (Go) apparatus dictyosome wrapping in a PC body.
Note also the abnormal stacking of endoplasmic reticulum (white asterisks) and a dense body
(arrow).D, A main PC dendrite (PCD) displays abnormal stacking of endoplasmic reticulum (*).
Arrowheads indicate asymmetric synapses between presynaptic parallel fiber boutons (p) and
postsynaptic PC dendritic spines (s). E, A PC dendritic spine (white s) is completely surrounded
by glia (G) and displays a postsynaptic density (arrow) free of a presynaptic partner. Another PC
spine (s) is innervated (arrowheads) by a presynaptic parallel fiber bouton (p). F, PC axon
terminals (Pa) make symmetric synapses (arrowheads) on dendrites of a deep nuclear neuron
(DCN). Scale bars: A, E, 500 nm; B, C, D, F, 2m.
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quent to deglycosylation, this signal was reduced to a major un-
glycosylated band at 17 kDa, indicating that Dpl is heavily
glycosylated, as described previously (Moore et al., 1999; Al Ber-
saoui et al., 2005). Additionally, a minor band at20 kDa, pre-
sumably representing the monoglycosylated form of Dpl, was
observed. Cerebral tissues from Chi3 mice on the three different
Prnp backgrounds revealed a fragment of similar size. This Dpl
form in Chi3 is indicative of a minor proteolytic cleavage of the
chimeric protein. This form is also observed inPrnpngsk/ngskmice,
which are known to develop ataxia. Thus, the cleaved formofDpl
might explain the toxicity of the chimeric protein, but only par-
tially because (1) the ataxia in Prnpngsk/ngsk mice developedmuch
later in age than inChi3mice and (2) theChi3mice on a tga20/
background did not develop severe ataxia.
The obvious ataxic phenotype in Chi3 Tgmice associated to the
very low expression level of Chi3 protein in the Tg mice, compared
with the innocuousness of the very high expression level of the Chi1
protein, led us to hypothesize that ataxia could result from the 33 aa
of the N-terminal portion ([25–57]) of Dpl. Indeed the Chi1 and
Chi3 proteins carry an identical N-terminal segment of PrP protein
([1–125]) but differ only by the length of their Dpl part, which is,
respectively, [58–179] and [25–179].Therefore, theneurotoxicityof
theDplpeptideD25–57was investigated in vitro. Primaryculturesof
cortical neurons from embryonic 17.5 dWTmice were exposed for
48 h to 40, 80, and 160 M of the peptide. Neuronal viability was
monitoredbymeasuring the reductionof themitochondrial activity
using the cell proliferation reagent CCK-8 assay. Treatment with
D25–57, but not with the control scrambled peptide, induced a sig-
nificant decrease of neuron viability in a concentration-dependent
manner (p 0.01; Fig. 10).
Discussion
Spontaneous neurodegenerative diseases have never been observed
in Tgmice expressing PrP-Dpl chimeric proteins. For the first time,
we report ataxia with cerebellar lesion in such a Tg mouse line. We
have developed and characterized three lines of Tg mice expressing
chimeric PrP-Dpl proteins that contain the CD of PrP. Our results
confirm that fusion of either the N terminus of PrP [1–135] or [1–
125] to, respectively, the [66–179] or [58–179] C-terminus part of
Dpl fails to provoke neurological disorder inTgChi2 andChi1mice
(Yoshikawa et al., 2008; Baumann et al., 2009). Unexpectedly, the
third chimeric protein (Chi3) composed of the N terminus of PrP
[1–124] linked toDpl [25–179] is neurotoxic inTgmice, resulting in
GC loss. Although a single line of Chi3 Tg mice was obtained, it is
extremely unlikely that the ataxia is not directly linked to the pres-
ence of the Chi3 transgene, (1) because ataxia is the common phe-
notype observed in Dpl-expressing Tg mice (Sakaguchi et al., 1996;
Moore et al., 2001; Rossi et al., 2001) and (2) because the ataxic
phenotype is rescued by PrPc overexpression as observedwith some
other Dpl Tgmice.
Histological analyses of brain fromTgmice expressing a low level
ofChi3 protein show severe cerebellar atrophywith reduction of the
PCL, whereas the number of PCs remains unchanged. However,
ultrastructural data indicate abnormalities in PCs, suggesting au-
tophagy, whereas GC degeneration is likely to be responsible for the
ataxic phenotype. It is noteworthy that Chi1 mice expressing a high
level of the sameN-terminal part of PrP grafted toDpl [58–179] do
not show any obvious lesions. In Prnp0/0 mice, Dpl toxicity specifi-
cally induces a loss of PCs only at an advanced age (Sakaguchi et al.,
1996;Moore et al., 2001;Rossi et al., 2001). InChi3mice,weobserve
a severe atrophy at a very early age of the cerebellum without a
significant reduction of PCs. The use of the half genomic vector to
construct Chi1, Chi2, andChi3 transgenesmay explain this discrep-
ancy since this vector is known to exclude the expression in PCs
(Shmerling et al., 1998; Karapetyan et al., 2009). PCs that lie at the
interface between the internal granular layer and themolecular layer
possess a wealth of synaptic connections with GCs. Hence, Chi3
expression inGCs, evenata lowlevel, is able tocompromisebothGC
and PC functions leading to ataxia.
Striking features of our result are the greatly enhanced toxicity of
Chi3 comparedwithDplTgmice [NgskPrnp-deficientmice orPrn-
pngsk/ngsk mice (Sakaguchi et al., 1996)] and the requirement for
muchhigher levels ofWTPrP topartially rescue theChi3phenotype
(Nishida et al., 1999). Indeed, even though Prnpngsk/ngsk mice ex-
press the Dpl transgene at approximately the same level as Chi3
mice, they exhibit ataxia and PC loss later in life, i.e., at 24 weeks of
age (Heitz et al., 2007), compared with 5-week-old for GC loss in
Chi3 Tg mice. Furthermore, whereas ataxia in Prnpngsk/ngsk is res-
cued by a single copy of Prnp, we show that the toxicity of Chi3
proteincanonlybepartially inhibitedwhenPrnp is overexpressedby
fourfold to fivefold. It is interesting to note that this phenotype in
Chi3 mice is also reminiscent of those described in mice expressing
PrP harboring 32–121, 32–134, 105–125, and 94–134 dele-
Figure 9. Glycosylation pattern of Chi3 brain proteins compared with that of WT mice and Prn-
p ngsk/ngskmice.T,Testisextract fromWTmice.Chi3miceareexpressedonmousePrnp/,Prnp 0/0,
andon tga20/backgroundwith ()orwithout ()PNGaseFpretreatment. Thirtymicrograms
of protein from total brain homogenates are subjected to PNGase F treatment as indicated and ana-
lyzed byWestern blot revealedwith rabbit anti-Dpl polyclonal antibody.
Figure10. Neurotoxic effect of D25–57doppel peptide onprimary cortical neurons fromembry-
onic 17.5 d WTmice. Neurons were chronically exposed to the indicated concentrations of D25–57
peptidefor48hat37°C.NeuronalviabilitywasmonitoredbyusingthecellproliferationreagentCCK-8
assay.Theneurotoxicityof160MP25–57peptidewasstatisticallysignificantaftera48hincubation
time compared with 40 and 80M and with the control scrambled peptide. Significant differences
(p0.01)were tested using a two-wayANOVABonferroni’spost hoc test.
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tions, which resulted in cerebellar atrophy and GC degeneration
(Shmerling et al., 1998; Baumann et al., 2007; Li et al., 2007).
Since the only difference between the proteins encoded by
Chi1 and Chi3 transgenes is the presence or absence of residues
23–57 from Dpl, we suggest that this segment of Dpl may repre-
sent an important toxicity-determining region. The dose-
dependent neurotoxic effect of D25–57 in primary mouse
embryonic cortical neurons supports this hypothesis. The pep-
tide concentration used might seem to be important, but a short
peptide does not reflect a full-length protein, which can be more
toxic because of its proper conformation and its natural cellular
environment. It would be interesting to investigate how this re-
gionmight play a role in the toxic activity of Dpl and whether the
mechanisms involved is similar to 23–31 PrP toxicity as discussed
by Harris and colleagues (Solomon et al., 2010;Westergard et al.,
2011). This could provide insights into understanding themolec-
ular mechanisms involved in the pathogenesis of prion disease
and more globally of neurodegenerative diseases.
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